JUPITER NEUROSCIENCES, INC. - JUNS

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.635M
QoQ value delta ($000)
-$753K (-31.53%)
Implied price effect (QoQ)
+45.7%
Shares
Total shares
638,871
QoQ shares delta
-720,694 (-53.01%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (JUNS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 13 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VESTOR CAPITAL, LLC 990 671 0.07%
VANGUARD GROUP INC 253 248,931 0.0%
GEODE CAPITAL MANAGEMENT, LLC 135 132,641 0.0%
Yorkville Advisors Global, LP 134 131,909 0.08%
Allen Capital Group, LLC 30 30,000 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 29 29,274 0.0%
NORTHERN TRUST CORP 25 25,346 0.0%
XTX Topco Ltd 21 21,500 0.0%
JANE STREET GROUP, LLC 14 14,457 0.0%
Russell Investments Group, Ltd. 3 3,000 0.0%
MidFirst Bank 1 1,000 0.0%
BANK OF AMERICA CORP /DE/ 0 142 0.0%